| British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris 2017 KE Harman, D Brown, LS Exton, RW Groves, PJ Hampton, ... British Journal of Dermatology 177 (5), 1170-1201, 2017 | 224 | 2017 |
| Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial HC Williams, F Wojnarowska, G Kirtschig, J Mason, TR Godec, E Schmidt, ... The Lancet 389 (10079), 1630-1638, 2017 | 211 | 2017 |
| Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study SK Mahil, N Dand, KJ Mason, ZZN Yiu, T Tsakok, F Meynell, B Coker, ... Journal of allergy and clinical immunology 147 (1), 60-71, 2021 | 173 | 2021 |
| Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and … ZZN Yiu, KJ Mason, PJ Hampton, NJ Reynolds, CH Smith, M Lunt, ... British Journal of Dermatology 183 (2), 294-302, 2020 | 106 | 2020 |
| Laugier-Hunziker syndrome: an important differential diagnosis for Peutz-Jeghers syndrome AK Lampe, PJ Hampton, K Woodford-Richens, I Tomlinson, CM Lawrence, ... Journal of medical genetics 40 (6), e77-e77, 2003 | 96 | 2003 |
| Comparison of drug discontinuation, effectiveness, and safety between clinical trial eligible and ineligible patients in BADBIR KJ Mason, JNWN Barker, CH Smith, PJ Hampton, M Lunt, K McElhone, ... JAMA dermatology 154 (5), 581-588, 2018 | 89 | 2018 |
| Drug survival associated with effectiveness and safety of treatment with guselkumab, ixekizumab, secukinumab, ustekinumab, and adalimumab in patients with psoriasis ZZN Yiu, G Becher, B Kirby, P Laws, NJ Reynolds, CH Smith, RB Warren, ... JAMA dermatology 158 (10), 1131-1141, 2022 | 79 | 2022 |
| Increased nuclear β‐catenin in suprabasal involved psoriatic epidermis PJ Hampton, OK Ross, NJ Reynolds British Journal of Dermatology 157 (6), 1168-1177, 2007 | 66 | 2007 |
| Implication for photosensitive patients of ultraviolet A exposure in vehicles PJ Hampton, PM Farr, BL Diffey, JJ Lloyd British journal of dermatology 151 (4), 873-876, 2004 | 49 | 2004 |
| Bullous pemphigoid triggered by swine flu vaccination: case report and review of vaccine triggered pemphigoid N Walmsley, P Hampton Journal of dermatological case reports 5 (4), 74, 2011 | 47 | 2011 |
| A case of Schöpf–Schulz–Passarge syndrome PJ Hampton, B Angus, AJ Carmichael Clinical and experimental dermatology 30 (5), 528-530, 2005 | 47 | 2005 |
| High prevalence of alcohol use disorders in patients with inflammatory skin diseases K Al‐Jefri, D Newbury‐Birch, CR Muirhead, E Gilvarry, V Araújo‐Soares, ... British journal of dermatology 177 (3), 837-844, 2017 | 38 | 2017 |
| Systemic medications used in treatment of common dermatological conditions: safety profile with respect to pregnancy, breast feeding and content in seminal fluid SM Brown, K Aljefri, R Waas, P Hampton Journal of Dermatological Treatment 30 (1), 2-18, 2019 | 37 | 2019 |
| Ustekinumab exposure during conception and pregnancy in patients with chronic plaque psoriasis: a case series of 10 pregnancies N Watson, K Wu, P Farr, NJ Reynolds, PJ Hampton British Journal of Dermatology 180 (1), 195-196, 2019 | 37 | 2019 |
| Prospective study in bullous pemphigoid: association of high serum anti‐BP180 IgG levels with increased mortality and reduced Karnofsky score MM Holtsche, S Goletz, N van Beek, D Zillikens, S Benoit, K Harman, ... British Journal of Dermatology 179 (4), 918-924, 2018 | 37 | 2018 |
| Lithium regulates keratinocyte proliferation via glycogen synthase kinase 3 and NFAT2 (nuclear factor of activated T cells 2) PJ Hampton, R Jans, RJ Flockhart, G Parker, NJ Reynolds Journal of cellular physiology 227 (4), 1529-1537, 2012 | 35 | 2012 |
| British Association of Dermatologists guidelines for the management of people with rosacea 2021 PJ Hampton, J Berth‐Jones, CE Duarte Williamson, R Hay, TA Leslie, ... British Journal of Dermatology 185 (4), 725-735, 2021 | 32 | 2021 |
| A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of … JR Chalmers, F Wojnarowska, G Kirtschig, AJ Nunn, DJ Bratton, J Mason, ... British Journal of Dermatology 173 (1), 227-234, 2015 | 28 | 2015 |
| Treatment of mucous membrane pemphigoid with the combination of mycophenolate mofetil, dapsone, and prednisolone: a case series K Staines, PJ Hampton Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 114 (1), e49-e56, 2012 | 25 | 2012 |
| An observer‐blinded randomized controlled pilot trial comparing localized immersion psoralen–ultraviolet A with localized narrowband ultraviolet B for the treatment of palmar … D Brass, T Fouweather, DD Stocken, C Macdonald, J Wilkinson, J Lloyd, ... British Journal of Dermatology 179 (1), 63-71, 2018 | 24 | 2018 |
